Douglas Fraker joins Rutgers Cancer Institute as surgeon-in-chief

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Douglas Fraker, an endocrine and oncologic surgeon, has joined Rutgers Robert Wood Johnson Medical School as chair of the Department of Surgery.

Fraker, who led the Division of Endocrine and Oncologic Surgery at the University of Pennsylvania, began his duties as department chair on Jan. 1. He leads the department in each of its mission areas, including the clinical arm, which is a component of Rutgers Health.

He also serves as surgeon-in-chief at Rutgers Cancer Institute of New Jersey and as chief of the surgical service at RWJBarnabas Health’s Robert Wood Johnson University Hospital—New Brunswick.

“One of the most attractive aspects of this job is the quality and dedication of the leadership across all divisions,” Fraker said in a statement. “As chair of surgery, I intend to work for them to allow each division to grow into a nationally recognized clinical enterprise.”

Fraker received his bachelor of arts degree in molecular biology from the University of Wisconsin. He graduated magna cum laude from Harvard Medical School, and completed his residency training in general surgery at the University of California, San Francisco.

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login